Uri Zilberman

VP, Corporate Development

2023 - Current

Strategic Accounts Corporate Develoopment

Investor (via RLI)

2016

https://www.zutacore.com/ Led the Pre-seed investment in the Company

Executive-In-Residence (EIR)

2022 - 2023

Supporting ZutaCore's CEO: Strategic Accounts, Strategy, Corporate Affairs.

Managing Partner

2016

Co-founder and General Partner @ RLI, an Early-stage Fund, focusing on early stage investments in the Israeli Market. Led business development, pre-seed investments, and helped launch 8 startups. Help develop, position, and execute early-stage Product, plans/activities, which resulted in all 8 companies raise Seed Capital. Portfolio companies include: #Zutacore #Carrar #Wellsheet #NewPhase Oversaw deal-flow, business development, and marketing activities to support Fund market presence and portfolio development. Communicated with Fund Limited Partners to ensure transparency. ► Screened >1,000 early stage Startups (B2B, US Market Focused). ► Helped define and drive portfolio companies to secure funding (Seed rounds). ► Sales and Business Development guidance in several Portfolio Companies. ► Portfolio companies, all still active, and raised significant fresh capital after Fund's investments. **The Fund ended its active investing period and as a result, not investing in new ventures**

Managing Partner

2020

Supporting Israeli Tech companies to launch / scale their businesses in the US. Corp-Dev / Business Development, Strategy, As-a-Service Crafting & executing business plans, to impact both top and bottom lines. Insight.Execution.Impact

Investor (via RLI)

2018

https://www.carrar.net/

Investor (via RLI)

2017

https://www.wellsheet.com/ Led the pre-seed investment in the Company

Investor (via RLI)

2017

Investor (via RLI)

2017

https://anchora-medical.com/

Investor (via RLI)

2017

Helping GiftCrowd in the various aspects of its business. Including: Strategy, Product Fit, G2M, Unit Economics, Funding.

Investor (via RLI)

2018

Executive-in-Residence (via Impact Ventures)

2020 - 2022

As Wren's EIR, I am responsible for the business strategy, sales and marketing, driving and guiding the leadership team (scientific team) and transforming the company to become a viable and scalable business entity. Track record of "moving fast" in "multiple domains" to achieve success. Building Sales to Wren's COVID-19, Saliva-PCR, Home-based testing solutions. Drove all G2M - Sales / Partnerships & Marketing efforts: ► Penetrated 5 Strategic Accounts and grew the business from insignificant business to a multi-million viable and profitable business; while experiencing >10x growth during my first year in the Company. ► Created relationships and alliances with Partners with strategic and long term values, offering new business models/concepts built for scale as well as exit path opportunities. Achieved Gross-Margins levels for physical products that are comparable to industry 'SW' metrics. ► Drove end-to-end marketing (website, social media, strategic marketing) to create presence, awareness and lead-generation. Positioned and created UVP in a competitive environment that differentiated Wren’s Product & Services. ► Redesigned Product in form & fit, designed for automation that allowed >30% cost reduction. ► Drove the scientific team to move faster, from 'comfort' to 'growth' zones.